Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 26. Mai 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8925  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178484  
   
Overdiagnosis in renal cancer: the hidden consequence of modern imaging.
Int Urol Nephrol
Vallecilla Valencia K, Garcia-Perdomo HA.
PMID: 42185723 [PubMed - as supplied by publisher]


ASO Author Reflections: Refining CT Heterogeneity Scoring to Improve Clear Cell Renal Cell Carcinoma Diagnosis in Small Renal Masses.
Ann Surg Oncol
Zhang W, Li X, Zhu X, Song X, Qu J.
PMID: 42185708 [PubMed - as supplied by publisher]


Impact of frailty on perioperative and oncologic outcomes after robotic radical prostatectomy: a multicenter study with competing risk analysis.
J Robot Surg
Rabie A, Dovey Z, Falavolti C, Papalia R, Signore S, Martini A, Marco MD, Balah A, Petitti T, Buscarini M, Zaytoun O.
PMID: 42185689 [PubMed - indexed for MEDLINE]


Multi-omics analysis reveals TM4SF19 as a diagnostic and prognostic biomarker in bladder cancer.
Discov Oncol
Aizezi X, Silafu B, Shi H, Huang J.
PMID: 42185687 [PubMed - as supplied by publisher]


Preoperative lung immune prognostic index (LIPI) predicts postoperative outcomes in clear cell renal cell carcinoma: a multicenter study.
Sci Rep
Pan Z, Li Y, Lou J, Shan S, Guo Y, Jiang S, He Q, Zhou G, Yang L.
PMID: 42185427 [PubMed - as supplied by publisher]


Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.
Nat Commun
Johnson JS, Miller JW, Hatoum F, Schell MJ, Yu X, Roman Souza G, Mizelle S, Gullapalli K, Fazili A, Jain R, Chatzkel J, Cen L, Dhillon J, Cubitt C, Yao J, Whiting J, Li J, Swank J, Jameel G, Zhang J, Wang X, Spiess PE, Fishman M, Chahoud J.
PMID: 42185255 [PubMed - as supplied by publisher]


NCCN Guideline Updates on Radiopharmaceutical Therapy for Prostate Cancer.
Eur Urol Focus
Ravi P, Dorff TB, Morgans AK.
PMID: 42185202 [PubMed - as supplied by publisher]


Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification.
Semin Diagn Pathol
Nguyen JK.
PMID: 42185133 [PubMed - as supplied by publisher]


Laparoscopic retroperitoneal lymph node dissection in testicular cancer: feasibility and safety at a tertiary center.
Cir Cir
Scavuzzo A, Calvo-Vázquez I, Reynoso-Noveron N, Pierzo-Lugo C, Barajas-Narvaez E, Jiménez-Ríos MA.
PMID: 42184400 [PubMed - indexed for MEDLINE]


Beyond the stone: nephrolithiasis as a metabolic sentinel in upper tract urothelial carcinoma and papillary renal cell carcinoma: toward a risk-stratified management framework.
Int Urol Nephrol
Wan S, Gao S, Huang K, Bai Y.
PMID: 42184081 [PubMed - as supplied by publisher]


A nomogram predicting the OS and CSS of ≥ T1b renal cell carcinoma patients after surgery.
Clin Transl Oncol
Zheng J, Wang H, Lv J, Liu C, Lan X, Xu T, Feng M.
PMID: 42184075 [PubMed - as supplied by publisher]


Improving Clear Cell Renal Cell Carcinoma Diagnosis: Modified CT Algorithms with Simplified Heterogeneity Scoring.
Ann Surg Oncol
Zhang W, Chen Q, Zhu X, Li X, Wang X, Ma H, Song X, Zheng Z, Qu J.
PMID: 42183967 [PubMed - as supplied by publisher]


Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer.
Ther Adv Med Oncol
Bilen MA, Lowentritt BH, Burbage S, Patel C, Rossi C, Kinkead F, Wong G, Pilon D, Shore ND.
PMID: 42182602 [PubMed]


Identification of shared diagnostic biomarkers and molecular pathways between chronic kidney disease and renal cell carcinoma using transcriptomics and machine learning.
Transl Cancer Res
Peng X, Wang Z, Si J, Ji H, Xu G, Chen Y, Du M, Xu M.
PMID: 42180890 [PubMed]


Low follow-up rate after positive prostate cancer screening in southern China: a community-based cross-sectional survey with a prospective component.
Front Public Health
Li ZQ, Li JR, Li Y, Liang YF, Bi JW, Li W.
PMID: 42180501 [PubMed - indexed for MEDLINE]


Application and challenges of smart responsive multifunctional nanoplatforms in integrated diagnosis and treatment of bladder cancer and overcoming therapeutic resistance.
Front Oncol
Chen L, Hang G, Wen Q, Ren L, Chen B.
PMID: 42180091 [PubMed]


Association between BK polyomavirus and prostate cancer: a systematic review and meta-analysis.
Front Oncol
Xiang B, Wang S, Zhang X, Zhao J, Zhang M, He J.
PMID: 42180090 [PubMed]


Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review.
Front Oncol
Cleanclay WD, Kintung IF, Kernyuy FB, Yensii NG, Fagbohun BO, Amadi EC, Kaze NN.
PMID: 42180075 [PubMed]


A prospective comparison of the diagnostic performance of a high b-value diffusion-weighted image-guided score versus PI-RADS v2.1 for transition zone prostate cancer.
Front Oncol
Li K, Xu T, Yan X, Mi S, Jiang M, Chen L, Kuang F.
PMID: 42180067 [PubMed]


JS-K induces autophagy-dependent ferroptosis in bladder cancer: a multimodal mechanistic and translational study.
Precis Clin Med
Li Z, Zhong H, Baptista-Hon D, Qiu J, Zhang Z, Zhang X, Zhao Y, Zhu L, Gao S, Li B, Monteiro O, Liu J, Zhuo Y.
PMID: 42179765 [PubMed]


   
   Artikel 1 - 20 / 178484    Seite 1 von 8925  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1